Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
J Cardiovasc Magn Reson. 2012 Mar 26;14(1):19. doi: 10.1186/1532-429X-14-19.
Thrombus aspiration (TA) has been shown to improve microvascular perfusion during primary percutaneous coronary intervention (PCI) for patients with ST-segment elevation myocardial infarction (STEMI). The objective of our study was to assess the relationship between TA and myocardial edema, myocardial hemorrhage, microvascular obstruction (MVO) and left ventricular remodeling in STEMI patients using cardiovascular magnetic resonance (CMR).
Sixty patients were enrolled post primary PCI and underwent CMR on a 1.5 T scanner at 48 hours and 6 months. Patients were retrospectively stratified into 2 groups: those that received TA (35 patients) versus that did not receive thrombus aspiration (NTA) (25 patients). Myocardial edema and myocardial hemorrhage were assessed by T2 and T2* quantification respectively. MVO was assessed via a contrast-enhanced T1-weighted inversion recovery gradient-echo sequence.
At 48 hours, infarct segment T2 (NTA 57.9 ms vs. TA 52.1 ms, p = 0.022) was lower in the TA group. Also, infarct segment T2* was higher in the TA group (NTA 29.3 ms vs. TA 37.8 ms, p = 0.007). MVO incidence was lower in the TA group (NTA 88% vs. TA 54%, p = 0.013).At 6 months, left ventricular end-diastolic volume index (NTA 91.9 ml/m2 vs. TA 68.3 ml/m2, p = 0.013) and left ventricular end systolic volume index (NTA 52.1 ml/m2 vs. TA 32.4 ml/m2, p = 0.008) were lower and infarct segment systolic wall thickening was higher in the TA group (NTA 3.5% vs. TA 74.8%, p = 0.003).
TA during primary PCI is associated with reduced myocardial edema, myocardial hemorrhage, left ventricular remodeling and incidence of MVO after STEMI.
血栓抽吸(TA)已被证明可改善 ST 段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)时的微血管灌注。我们的研究目的是使用心血管磁共振(CMR)评估 TA 与 STEMI 患者心肌水肿、心肌出血、微血管阻塞(MVO)和左心室重构之间的关系。
60 例患者在初次 PCI 后入组,并在 1.5T 扫描仪上于 48 小时和 6 个月时进行 CMR。患者回顾性分为 2 组:接受 TA(35 例)与未接受血栓抽吸(NTA)(25 例)。通过 T2 和 T2*定量评估心肌水肿和心肌出血。通过对比增强 T1 加权反转恢复梯度回波序列评估 MVO。
在 48 小时时,TA 组梗死节段 T2(NTA 57.9ms 比 TA 52.1ms,p=0.022)较低。此外,TA 组梗死节段 T2*较高(NTA 29.3ms 比 TA 37.8ms,p=0.007)。TA 组 MVO 发生率较低(NTA 88%比 TA 54%,p=0.013)。在 6 个月时,左室舒张末期容积指数(NTA 91.9ml/m2 比 TA 68.3ml/m2,p=0.013)和左室收缩末期容积指数(NTA 52.1ml/m2 比 TA 32.4ml/m2,p=0.008)较低,且 TA 组梗死节段收缩期壁增厚较高(NTA 3.5%比 TA 74.8%,p=0.003)。
在初次 PCI 期间进行 TA 与 STEMI 后心肌水肿、心肌出血、左心室重构和 MVO 发生率降低有关。